WCN26-3341 A Rare Case of Pseudohypoaldosteronism Type II or Gordon Syndrome

Read full text Summarise with VIRAT
Authors: KEBRON YUSUF
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pseudohypoaldosteronism type II (PHA II) or Gordon Syndrome is a rare, autosomally inherited disease with unknown prevalence. It is caused by mutations in the WNK1, WNK4, CUL3, or KLHL3 gene. It is characterized by hypertension, hyperkalemia, hyperchloremic metabolic acidosis and low plasma aldosterone levels, but otherwise normal kidney function. The age of onset of PHA2 is variable, ranging from infancy or childhood to adolescence and adulthood. The electrolyte and blood pressure abnormalities of PHA II are often managed with salt restriction and hydrochlorothiazide (HCTZ).

Fields of Study & Subjects

Hormonal Regulation and Hypertension Ion Transport and Channel Regulation Potassium and Related Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105416–105416
Publication date
25 March 2026
Language
EN